External artificial pancreas improves glucose control, reduces hypoglycemia risk

Share this content:
External artificial pancreas improves glucose control, reduces hypoglycemia risk
External artificial pancreas improves glucose control, reduces hypoglycemia risk
The world's first clinical trial comparing three alternative treatments for type 1 diabetes was conducted in Montréal by researchers at the IRCM and the University of Montreal, led by endocrinologist Dr. The study confirms that the external artificial pancreas improves glucose control and reduces the risk of hypoglycemia compared to conventional diabetes treatment.
READ FULL ARTICLE From News Medical
Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

is free, fast, and customized just for you!




Already a member?

Sign In Now »